View in EDS

1520MO Phase I first-in-human study of a novel anti-CD137 switch antibody agonist STA551 (STA) as monotherapy and in combination with atezolizumab (atezo) in patients (pts) with advanced solid tumors.

Saved in:
Bibliographic Details
Title: 1520MO Phase I first-in-human study of a novel anti-CD137 switch antibody agonist STA551 (STA) as monotherapy and in combination with atezolizumab (atezo) in patients (pts) with advanced solid tumors.
Authors: Silva, D.1 (AUTHOR), Doi, T.2 (AUTHOR), Koganemaru, S.2 (AUTHOR), Thistlethwaite, F.3 (AUTHOR), Zair, Z.3 (AUTHOR), Yamamoto, N.4 (AUTHOR), Koyama, T.4 (AUTHOR), Inatani, M.5 (AUTHOR), Hashimoto, A.6 (AUTHOR), Takeshita, H.7 (AUTHOR), Takano, Y.8 (AUTHOR), Higashikawa, K.8 (AUTHOR), Ikeda, S.5 (AUTHOR), Tomita, H.9 (AUTHOR), Kanai, Y.5 (AUTHOR), Banerji, U.1 (AUTHOR)
Source: Annals of Oncology. 2025 Supplement 2, Vol. 36, pS911-S912. 2p.
Database: Academic Search Ultimate
FullText Text:
  Availability: 0
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 189419943
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: 1520MO Phase I first-in-human study of a novel anti-CD137 switch antibody agonist STA551 (STA) as monotherapy and in combination with atezolizumab (atezo) in patients (pts) with advanced solid tumors.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Silva%2C+D%2E%22">Silva, D.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Doi%2C+T%2E%22">Doi, T.</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Koganemaru%2C+S%2E%22">Koganemaru, S.</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Thistlethwaite%2C+F%2E%22">Thistlethwaite, F.</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Zair%2C+Z%2E%22">Zair, Z.</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Yamamoto%2C+N%2E%22">Yamamoto, N.</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Koyama%2C+T%2E%22">Koyama, T.</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Inatani%2C+M%2E%22">Inatani, M.</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Hashimoto%2C+A%2E%22">Hashimoto, A.</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Takeshita%2C+H%2E%22">Takeshita, H.</searchLink><relatesTo>7</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Takano%2C+Y%2E%22">Takano, Y.</searchLink><relatesTo>8</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Higashikawa%2C+K%2E%22">Higashikawa, K.</searchLink><relatesTo>8</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Ikeda%2C+S%2E%22">Ikeda, S.</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Tomita%2C+H%2E%22">Tomita, H.</searchLink><relatesTo>9</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Kanai%2C+Y%2E%22">Kanai, Y.</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Banerji%2C+U%2E%22">Banerji, U.</searchLink><relatesTo>1</relatesTo> (AUTHOR)
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Annals+of+Oncology%22">Annals of Oncology</searchLink>. 2025 Supplement 2, Vol. 36, pS911-S912. 2p.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=189419943
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.annonc.2025.08.2151
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 2
        StartPage: S911
    Titles:
      – TitleFull: 1520MO Phase I first-in-human study of a novel anti-CD137 switch antibody agonist STA551 (STA) as monotherapy and in combination with atezolizumab (atezo) in patients (pts) with advanced solid tumors.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Silva, D.
      – PersonEntity:
          Name:
            NameFull: Doi, T.
      – PersonEntity:
          Name:
            NameFull: Koganemaru, S.
      – PersonEntity:
          Name:
            NameFull: Thistlethwaite, F.
      – PersonEntity:
          Name:
            NameFull: Zair, Z.
      – PersonEntity:
          Name:
            NameFull: Yamamoto, N.
      – PersonEntity:
          Name:
            NameFull: Koyama, T.
      – PersonEntity:
          Name:
            NameFull: Inatani, M.
      – PersonEntity:
          Name:
            NameFull: Hashimoto, A.
      – PersonEntity:
          Name:
            NameFull: Takeshita, H.
      – PersonEntity:
          Name:
            NameFull: Takano, Y.
      – PersonEntity:
          Name:
            NameFull: Higashikawa, K.
      – PersonEntity:
          Name:
            NameFull: Ikeda, S.
      – PersonEntity:
          Name:
            NameFull: Tomita, H.
      – PersonEntity:
          Name:
            NameFull: Kanai, Y.
      – PersonEntity:
          Name:
            NameFull: Banerji, U.
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 02
              M: 09
              Text: 2025 Supplement 2
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-print
              Value: 09237534
          Numbering:
            – Type: volume
              Value: 36
          Titles:
            – TitleFull: Annals of Oncology
              Type: main
ResultId 1